Please login to the form below
British Medical Journal
This page shows the latest British Medical Journal news and features for those working in and with pharma, biotech and healthcare.
Half of European cancer drug trials ‘biased’, says BMJ
The paper – published in the British Medical Journal– examined 41 published trials reported between 2014 and 2016 that were used as evidence to support the approval of 32 cancer drugs.
Latest news
-
Amgen, Servier start second phase 3 trial of heart failure hope
Exercise intolerance, typically manifested by shortness of breath and fatigue on exertion, is a predominant symptom of chronic heart failure and often the first symptom that prompts patients to seek medical ... A recent British Medical Journal study
-
ABPI bid to overturn NICE’s budget impact rules fails
The Association of the British Pharmaceutical Industry (ABPI) has been fighting a legal action to try to overturn NICE’s introduction of a £20m cost ceiling for new drugs that have ... Last year, the NHS spent £16.8bn on medicines, according to the
-
Audit exposes gaps in pharma's promises on trial transparency
The audit - which is published in the British Medical Journal - reveals that the commitments made by pharma companies were ‘highly variable’.
-
NICE agrees £20m cost ceiling for new drugs
Last year, the NHS spent £16.8bn on medicines, according to the British Medical Journal, up 8% on the prior year and almost £4bn more than was spent in 2011. ... NICE has indicated they would consider broadening the fast-track approach to a wider group
-
Bayer defends Xarelto as pivotal trial scrutinised
Last week, the British Medical Journal also reported that the results of the trial are under scrutiny from regulators, specifically concerns that they may have exaggerated Xarelto's benefits.
Amgen, Servier start second phase 3 trial of heart failure hope
ABPI bid to overturn NICE’s budget impact rules fails
Audit exposes gaps in pharma's promises on trial transparency
NICE agrees £20m cost ceiling for new drugs
Bayer defends Xarelto as pivotal trial scrutinised
More from news
Approximately 1 fully matching, plus 97 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
The role of publishers. There are examples of individual publications such as the British Medical Journal that are exploring the potential for patient involvement throughout the publication process, for example by ... using patient peer reviewers,
-
The Chinese diabetes challenge
according to a study recently published in the Journal of the American Medical Association (JAMA). ... Even the British Medical Journal (BMJ) has acknowledged that traditional Chinese medicine and Western medicine 'sit side-by-side' in China; therefore
-
Country report: The healthcare market in Japan
The number of suicides rose after the Kobe earthquake in 1995, which killed nearly 6, 500 people and the British Medical Journal reported in September 2011 that 'Japan's suicide rate ... Patients favour medical technology, such as scans, having them
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
The Chinese diabetes challenge
Country report: The healthcare market in Japan
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
M3 appoints Simon Walker as director of education
During this time he held senior sales positions with the British Medical Journal and in addition to this has also provided freelance consultancy services to agencies, pharmaceutical companies and publishers. ... It’s leading the field in medical
-
M3 appoints Paul Rice as chief operating officer
The company has also appointed Simon Walker as a business director working across its portfolio of promotional and medical education solutions on a global basis. ... Walker has over 20 years experience with the BMJ (British Medical Journal) and has also
M3 appoints Simon Walker as director of education
M3 appoints Paul Rice as chief operating officer
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
An article in the British Medical Journal (BMJ). 1. in October 2020 found:. ... More effective medicines and medical interventions created because women were included in clinical trials.
-
WHITE PAPER: What's missing in women's health?
Hamoda H. British Menopause Society further update on HRT supply shortages – 27th January 2020. ... women irreversibly harmed. British Medical Journal.
-
Practical Patient Centricity
addressing unmet medical needs, lives are improved and extended. ... The British Medical Journal requires companies to indicate the level of patient involvement in manuscripts for example.
-
Is Technology Harming Your Brain?
A Difference of Opinion. The article referenced a piece from the British Medical Journal in which three leading academics challenge Baroness Greenfield’s assertions.
Why it’s in everyone’s interest the Women’s Health Strategy for England succeeds
WHITE PAPER: What's missing in women's health?
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
-
Digital account director
-
Competitive
-
Events Executive
-
Depending on Experience
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
- Onyx Health Launch Creative Studio After Record Year
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Tonix Pharmaceuticals to develop TNX-102 for long COVID syndrome
- Migraine-friendly colours for the home
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
